TAF9 antibody (N-Term)
Quick Overview for TAF9 antibody (N-Term) (ABIN7188511)
Target
See all TAF9 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Purpose
- AK6 Antibody
-
Cross-Reactivity
- Mouse, Rat
-
Purification
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from the N-terminal region of Human AK6.
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- TAF9 (RNA Polymerase II TBP-Associated Factor Subunit G (TAF9))
-
Alternative Name
- AK6
-
Background
- AD-004 antibody, Adenylate kinase isoenzyme 6 antibody, Adrenal gland protein AD-004 antibody, AK/ATPase antibody, AK6 antibody, CGI-137 antibody, CIP antibody, Coilin-interacting nuclear ATPase protein antibody, Dual activity adenylate kinase/ATPase antibody, hCINAP antibody, KAD6_HUMAN antibody, TAF9 antibody
-
UniProt
- Q9Y3D8
-
Pathways
- Negative Regulation of intrinsic apoptotic Signaling
Target
-